Assisted dying is available in many countries globally but remains illegal in the UK, where there are ongoing debates about its legal status. Britons seeking an assisted death must travel to Switzerland. This article explores the experiences of UK-based individuals considering an assisted death and family members of those who have completed an assisted death. We recruited 11 participants across two qualitative studies, analyzing data using Interpretative Phenomenological Analysis. These results indicated four themes: the "" of illness; the value of autonomy and control over death; the difficulties of talking about assisted dying; and the barriers associated with pursuing an assisted death. The findings suggest there are individuals in the UK who will seek an assisted death, despite its illegality. Those involved in these journeys are not currently able to access support and more needs to be done to ensure their needs are met.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/07481187.2024.2414264 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hijacking the hyaluronan assisted iron endocytosis to promote the ferroptosis in anticancer photodynamic therapy.
Carbohydr Polym
March 2025
State Key Laboratory of Complex Severe and Rare Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, PR China. Electronic address:
Photodynamic therapy (PDT) eradicates tumor cells by the light-stimulated reactive oxygen species, which also induces lipid peroxidation (LPO) and subsequently ferroptosis, an iron-depended cell death. Ferroptosis has a tremendous therapeutic potential in cancer treatment, however, the ferroptosis efficiency is largely limited by the available iron in cells. Through hijacking the CD44-mediated iron endocytosis of hyaluronan (HA), here PDT with enhanced ferroptosis was realized by a HA@Ce6 nanogel self-assembled from HA, a photosensitizer Chlorin e6 (Ce6) and Fe as cross-linkers.
View Article and Find Full Text PDFMultiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions.
Am J Cardiol
January 2025
Cardiology Division, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Baim Institute for Clinical Research, Boston, MA, USA. Electronic address:
There are limited tools available to predict the long-term prognosis of persons with coronary chronic total occlusions (CTO). A previously-described blood biomarker panel to predict cardiovascular (CV) events was evaluated in patients with CTO. From 1251 patients in the CASABLANCA study, 241 participants with a CTO were followed for an average of 4 years for occurrence of major adverse CV events (MACE, CV death, non-fatal myocardial infarction or stroke) and CV death/heart failure (HF) hospitalization.
View Article and Find Full Text PDFEarly detection of carcinoma: correlating quantifiable tumor biomarkers with high-resolution microscopy (HRME) findings.
Expert Rev Mol Diagn
January 2025
Department of Electronics and Communication Engineering, IIITDM Kancheepuram, Chennai, India.
Introduction: Cancer ranks as the second most prevalent cause of death worldwide, responsible for approximately 9.6 million deaths annually. Approximately one out of every six deaths is caused by cancer.
View Article and Find Full Text PDFThe British Geriatrics Society's position on assisted dying.
Age Ageing
January 2025
Medicine Clinical Board, University Hospital of Wales Cardiff, Cardiff, UK.
In response to increased focus on the issue of Assisted Dying (AD) in the UK due to the presentation of The Terminally Ill Adults (End of Life) Bill 2024-25 [1] and bills before parliaments in the Isle of Man, Guernsey and Scotland, the British Geriatric Society (BGS) recently developed a position statement opposing legalisation of AD in the UK [2]. We set out our key reasoning behind this position, namely the current adverse health and social care context and significant concern about whether effective safeguards can be created to protect older people with complex needs from undue harms. The BGS asks for improved, personalised, multidisciplinary care for older people at the end of their lives, including high-quality palliative and end-of-life care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!